BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

330 related articles for article (PubMed ID: 24388773)

  • 1. α4 contributes to bladder urothelial carcinoma cell invasion and/or metastasis via regulation of E-cadherin and is a predictor of outcome in bladder urothelial carcinoma patients.
    Liu J; Cai M; Chen J; Liao Y; Mai S; Li Y; Huang X; Liu Y; Zhang J; Kung H; Zeng Y; Zhou F; Xie D
    Eur J Cancer; 2014 Mar; 50(4):840-51. PubMed ID: 24388773
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Solute carrier family 12 member 5 promotes tumor invasion/metastasis of bladder urothelial carcinoma by enhancing NF-κB/MMP-7 signaling pathway.
    Liu JY; Dai YB; Li X; Cao K; Xie D; Tong ZT; Long Z; Xiao H; Chen MK; Ye YL; Liu B; Tan J; Tang J; Xu ZZ; Gan Y; Zhou YH; Deng F; He LY
    Cell Death Dis; 2017 Mar; 8(3):e2691. PubMed ID: 28333147
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment with low-dose interferon-alpha restores the balance between matrix metalloproteinase-9 and E-cadherin expression in human transitional cell carcinoma of the bladder.
    Slaton JW; Karashima T; Perrotte P; Inoue K; Kim SJ; Izawa J; Kedar D; McConkey DJ; Millikan R; Sweeney P; Yoshikawa C; Shuin T; Dinney CP
    Clin Cancer Res; 2001 Sep; 7(9):2840-53. PubMed ID: 11555602
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Slug contributes to cadherin switch and malignant progression in muscle-invasive bladder cancer development.
    Wu K; Zeng J; Zhou J; Fan J; Chen Y; Wang Z; Zhang T; Wang X; He D
    Urol Oncol; 2013 Nov; 31(8):1751-60. PubMed ID: 22421353
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of thymosin β4 in the regulation of epithelial-mesenchymal transformation in urothelial carcinoma.
    Wang ZY; Zeng FQ; Zhu ZH; Jiang GS; Lv L; Wan F; Dong R; Xiao XY; Xing SA
    Urol Oncol; 2012; 30(2):167-76. PubMed ID: 20864366
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bladder Tumor Subtype Commitment Occurs in Carcinoma
    Wullweber A; Strick R; Lange F; Sikic D; Taubert H; Wach S; Wullich B; Bertz S; Weyerer V; Stoehr R; Breyer J; Burger M; Hartmann A; Strissel PL; Eckstein M
    Cancer Res; 2021 Mar; 81(6):1552-1566. PubMed ID: 33472889
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Down-regulation of HMGB1 expression by shRNA constructs inhibits the bioactivity of urothelial carcinoma cell lines via the NF-κB pathway.
    Huang Z; Zhong Z; Zhang L; Wang X; Xu R; Zhu L; Wang Z; Hu S; Zhao X
    Sci Rep; 2015 Aug; 5():12807. PubMed ID: 26239046
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular factors regulating E-cadherin expression in urothelial bladder cancer and their correlations with the clinicopathological features.
    Hussein S; Mosaad H; Rashed HE; Ahmed S; Ragab A; Ismail EI
    Mol Biol Rep; 2017 Aug; 44(4):365-377. PubMed ID: 28808805
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Loss of DeltaNp63alpha promotes invasion of urothelial carcinomas via N-cadherin/Src homology and collagen/extracellular signal-regulated kinase pathway.
    Fukushima H; Koga F; Kawakami S; Fujii Y; Yoshida S; Ratovitski E; Trink B; Kihara K
    Cancer Res; 2009 Dec; 69(24):9263-70. PubMed ID: 19934319
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Detection, verification and significance of differentially expressed miRNAs in bladder urothelial carcinoma].
    Xie P; Xu F; Cheng W; Gao JP; Zhang ZY; Ge JP; Wei ZF; Xu XF
    Zhonghua Yi Xue Za Zhi; 2010 Dec; 90(48):3391-4. PubMed ID: 21223810
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of transcription factor Twist1 in bladder urothelial carcinoma and its clinical significance.
    Tang X; Xing J; Li W; Wu Z; Zhang K; Zheng J
    J BUON; 2013; 18(1):211-9. PubMed ID: 23613408
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Foxo3a suppression of urothelial cancer invasiveness through Twist1, Y-box-binding protein 1, and E-cadherin regulation.
    Shiota M; Song Y; Yokomizo A; Kiyoshima K; Tada Y; Uchino H; Uchiumi T; Inokuchi J; Oda Y; Kuroiwa K; Tatsugami K; Naito S
    Clin Cancer Res; 2010 Dec; 16(23):5654-63. PubMed ID: 21138866
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MiR-429 reverses epithelial-mesenchymal transition by restoring E-cadherin expression in bladder cancer.
    Wu CL; Ho JY; Chou SC; Yu DS
    Oncotarget; 2016 May; 7(18):26593-603. PubMed ID: 27058893
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ARID1A upregulation predicts better survival in patients with urothelial bladder carcinoma.
    Cao Q; Wang C; Ding Y; Xu D; Qian S; Shen H; Qi J
    J Int Med Res; 2020 Apr; 48(4):300060519895687. PubMed ID: 31891283
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sp1 is overexpressed and associated with progression and poor prognosis in bladder urothelial carcinoma patients.
    Zhu J; Lu Z; Ke M; Cai X
    Int Urol Nephrol; 2022 Jul; 54(7):1505-1512. PubMed ID: 35467245
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The adenosine A2b receptor promotes tumor progression of bladder urothelial carcinoma by enhancing MAPK signaling pathway.
    Zhou Y; Chu X; Deng F; Tong L; Tong G; Yi Y; Liu J; Tang J; Tang Y; Xia Y; Dai Y
    Oncotarget; 2017 Jul; 8(30):48755-48768. PubMed ID: 28548944
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Estrogen receptor β (ERβ) is a novel prognostic marker of recurrence survival in non-muscle-invasive bladder cancer potentially by inhibiting cadherin switch.
    Han B; Cui D; Jing Y; Hong Y; Xia S
    World J Urol; 2012 Dec; 30(6):861-7. PubMed ID: 22238119
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High expression of Notch ligand Jagged2 is associated with the metastasis and recurrence in urothelial carcinoma of bladder.
    Li W; Liu M; Feng Y; Huang YF; Xu YF; Che JP; Wang GC; Zheng JH
    Int J Clin Exp Pathol; 2013; 6(11):2430-40. PubMed ID: 24228105
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epithelial-To-Mesenchymal Transition and Its Correlation With Clinicopathologic Features in Patients With Urothelial Carcinoma of the Bladder.
    Singh R; Ansari JA; Maurya N; Mandhani A; Agrawal V; Garg M
    Clin Genitourin Cancer; 2017 Apr; 15(2):e187-e197. PubMed ID: 27601277
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The ERH gene regulates migration and invasion in 5637 and T24 bladder cancer cells.
    Pang K; Zhang Z; Hao L; Shi Z; Chen B; Zang G; Dong Y; Li R; Liu Y; Wang J; Zhang J; Cai L; Han X; Han C
    BMC Cancer; 2019 Mar; 19(1):225. PubMed ID: 30866868
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.